DSM N.V.

amsterdam : DSM


May 03, 2013 12:25 ET

DSM announces results of Annual General Meeting of Shareholders

HEERLEN, NETHERLANDS--(Marketwired - May 3, 2013) -



Royal DSM today held its Annual General Meeting of Shareholders.

The following items were approved:

  * Adoption of the Financial Statements for 2012
  * Adoption of the dividend for 2012 (see also separate press release)
  * Release from liability of the members of the Managing Board and
    Supervisory Board for their responsibilities in the financial year 2012
  * Appointment of Mr. D. de Vreeze as a member of the Managing Board
  * Reappointment of Mr. P. Hochuli as a member of the Supervisory Board
  * Adjustment of the remuneration policy for the Managing Board
  * Extension of the period during which the Managing Board is authorized
    to issue ordinary shares and to limit or exclude the preferential right
    when issuing ordinary shares
  * Authorization of the Managing Board to have the company repurchase
    shares
  * Reduction of the issued capital by canceling shares

DSM - Bright Science. Brighter Living.™

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio- based materials. DSM's 23,500 employees deliver annual net sales of around EUR9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.


Press release-pdf: http://hugin.info/130663/R/1699046/560338.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE

[HUG#1699046]

Contact Information

  • For more information:
    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    e-mail Email Contact


    DSM Investor Relations
    Dave Huizing
    tel. +31 (0) 45 5782864
    fax +31 (0) 10 4590275
    e-mail Email Contact